相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits
Ting Cao et al.
FRONTIERS IN PHARMACOLOGY (2021)
Progesterone receptor membrane associated component 1 enhances obesity progression in mice by facilitating lipid accumulation in adipocytes
Ryogo Furuhata et al.
COMMUNICATIONS BIOLOGY (2020)
Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and Disease
Nicholas J. Izzo et al.
ENEURO (2020)
Quantitative monitoring of a panel of stress-induced biomarkers in human plasma by liquid chromatography-tandem mass spectrometry: an application in a comparative study between depressive patients and healthy subjects
HuaLin Cai et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia
Diana Mareta I. F. A. Pitaloka et al.
NUTRITION RESEARCH (2019)
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
Elena G. Kornetova et al.
FRONTIERS IN PSYCHIATRY (2019)
Effects of progesterone on glucose uptake in neurons of Alzheimer's disease animals and cell models
Hang Wu et al.
LIFE SCIENCES (2019)
Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1
Kaia K. Hampton et al.
MOLECULAR PHARMACOLOGY (2018)
CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats treated with sitagliptin
Zeynep Mine Coskun et al.
PHARMACOLOGICAL REPORTS (2017)
Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways
H. L. Cai et al.
TRANSLATIONAL PSYCHIATRY (2017)
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
Xuemei Liu et al.
SCIENTIFIC REPORTS (2017)
Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance
Yasuaki Kabe et al.
NATURE COMMUNICATIONS (2016)
Regulation of glucose metabolism from a liver-centric perspective
Hye-Sook Han et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
A potential mechanism underlying atypical antipsychotics-induced lipid disturbances
H. L. Cai et al.
TRANSLATIONAL PSYCHIATRY (2015)
The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes
Uyen B. Chu et al.
EBIOMEDICINE (2015)
GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice
Qian Wang et al.
CLINICAL SCIENCE (2014)
Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells
Ming Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Rachel J. Perry et al.
NATURE (2014)
The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect
G. C. Smith et al.
PSYCHOPHARMACOLOGY (2014)
Investigation of the metabolic effects of chronic clozapine treatment on CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats
Csaba Hegedues et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier
A. Menga et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models
Zhiyong Cheng et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Global Gene Expression Profiles of Subcutaneous Adipose and Muscle From Glucose-Tolerant, Insulin-Sensitive, and Insulin-Resistant Individuals Matched for BMI
Steven C. Elbein et al.
DIABETES (2011)
FoxOs Function Synergistically to Promote Glucose Production
Rebecca A. Haeusler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PGRMC1 (progesterone receptor membrane component 1): A targetable protein with multiple functions in steroid signaling, P450 activation and drug binding
Hannah J. Rohe et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: Implications for glucose metabolism and food choice behaviour
Greg C. Smith et al.
SCHIZOPHRENIA RESEARCH (2009)
Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
G. C. Smith et al.
DIABETOLOGIA (2008)
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats:: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063
Marie-Bernadette Assie et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production
Lena Danovich et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain
G. D. Cooper et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Progesterone impairs cell respiration and suppresses a compensatory increase in glucose transport in isolated rat skeletal muscle:: a non-genomic mechanism contributing to metabolic adaptation to late pregnancy?
F. Gras et al.
DIABETOLOGIA (2007)
Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells
D. Wu et al.
DIABETOLOGIA (2007)
Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: Implications for adverse metabolic effects
Karen L. Houseknecht et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Clozapine-induced alteration of glucose homeostasis in the rat: The contribution of hypothalamic-pituitary-adrenal axis activation
Giovanni Tulipano et al.
NEUROENDOCRINOLOGY (2007)
The atypical antipsychotic clozapine impairs insulin secretion by inhibiting glucose metabolism and distal steps in rat pancreatic islets
N. Sasaki et al.
DIABETOLOGIA (2006)
Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents
Vance L. Albaugh et al.
OBESITY (2006)
The effects of clozapine on the GSK-3-mediated signaling pathway
UG Kang et al.
FEBS LETTERS (2004)
Adverse metabolic effects associated with atypical antipsychotics - Literature review and clinical implications
K Melkersson et al.
DRUGS (2004)
Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents
CE Marx et al.
NEUROPSYCHOPHARMACOLOGY (2003)
分享论文
